메뉴 건너뛰기




Volumn 52, Issue 10, 2012, Pages 2225-2233

Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: A Cardiovascular Cell Therapy Research Network (CCTRN) study

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOLOGOUS BONE MARROW MONONUCLEAR CELL TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL THERAPY; CELL TRANSPLANTATION; GOOD MANUFACTURING PRACTICE; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; QUALITY CONTROL; TURNAROUND TIME;

EID: 84868301700     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03543.x     Document Type: Article
Times cited : (4)

References (9)
  • 1
  • 7
    • 70849134277 scopus 로고    scopus 로고
    • Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers
    • Sutherland DR, Nayyar R, Acton E, Giftakis A, Dean S, Mosiman VL,. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers. Cytotherapy 2009; 11: 595-605.
    • (2009) Cytotherapy , vol.11 , pp. 595-605
    • Sutherland, D.R.1    Nayyar, R.2    Acton, E.3    Giftakis, A.4    Dean, S.5    Mosiman, V.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.